Yes! For over 20 years, we’ve been industry leaders synthesizing high quality research and diagnostic grade material, especially difficult and unusual constructs. We combine our expertise with a state-of-the art GMP manufacturing facility to offer mRNA, oligonucleotide and small molecule therapeutic development and production services, tailored for your specific applications.

TriLink can ensure methods and materials are compatible with GMP manufacturing requirements from the start of your research project. From idea conception to early human trials, TriLink is an expert partner. We offer consultation on compound design, material grade, process development, scale up and cGMP production. TriLink delivers consistent quality API on schedule, regardless of the scale. Plus, TriLink provides supporting documentation to streamline the IND submission process and carry you through to clinical trials – making the process efficient and cost effective.

TriLink has successfully taken targets from small, research grade syntheses through to large scale cGMP batches, including upwards of 10 grams of mRNA therapeutic compounds. We offer a wide range of manufacturing scales enabling you to specify the exact amount of material required for IND-enabling tox studies and early phase clinical studies.

With nine dedicated GMP manufacturing suites and two support labs, TriLink has the agility to meet most timelines by implementing and managing multiple projects in parallel. Our PMP certified project management team will ensure your product is delivered on time and on budget. Open communication and regularly scheduled updates throughout the manufacturing process will keep you  apprised of progress.

We know drug development is complicated, leverage our experience to ensure your success.

Request a GMP Consultation today: